Advertisement
Please Note: All Allergan-supported scientific posters are embargoeduntil 8:00 a.m. EST on Friday, February 1, 2008
Important BOTOX(R) Cosmetic (Botulinum Toxin Type A) Information
Advertisement
BOTOX(R) Cosmetic is indicated for the temporary improvement in theappearance of moderate to severe frown lines between the brows in people 18 to65 years of age.
Important BOTOX(R) Cosmetic (Botulinum Toxin Type A) Safety Information
Serious heart problems and serious allergic reactions have been reportedrarely. If you think you are having an allergic reaction or other unusualsymptoms, such as difficulty swallowing, speaking or breathing, call yourdoctor immediately. The most common side effects following injection includetemporary eyelid droop and nausea. Localized pain, infection, inflammation,tenderness, swelling, redness and/or bleeding/bruising may be associated withthe injection. Patients with certain neuromuscular disorders such as ALS,myasthenia gravis or Lambert-Eaton syndrome may be at increased risk ofserious side effects. For full prescribing information, please visitwww.botoxcosmetic.com.
Important JUVEDERM(TM) Dermal Filler Prescribing Information
JUVEDERM(TM) is indicated for injection into the mid to deep dermis forcorrection of moderate to severe facial wrinkles and folds (such as nasolabialfolds), and is generally well tolerated. In clinical studies, adverse eventswere usually mild to moderate in nature, did not require intervention andlasted seven days or less. The most common side effects included temporaryinjection site reactions including redness, pain/tenderness, firmness,swelling, lumps and bumps and bruising. For complete patient safety andprescribing information, please visit www.Juvederm.com.
(R) marks owned by Allergan, Inc.
JUVEDERM(TM) is a mark owned by Corneal Industrie SASWhat: AAD 2008 Winter Meeting: Poster Presentations When: Friday, February 1 - Tuesday, February 5, 2008 Where: Hall A at the Henry B. Gonzalez Convention Center, San Antonio, TX
SOURCE Allergan, Inc.
